Back to Trades
Pinkas Jan
Chief Scientific OfficerCIK 0002077126
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, Pinkas Jan, Chief Scientific Officer, has disclosed $2.8M in transactions — all concentrated in CRESCENT BIOPHARMA, INC. (CBIO). Their disclosed trades are heavily weighted toward selling — $0 in buys and $34.9K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Sep 18 | CBIO CRESCENT BIOPHARMA, INC. | Pinkas Jan | Chief Scientific Officer | Sell | $11.8K |
| Jun 23 | CBIO CRESCENT BIOPHARMA, INC. | Pinkas Jan | Chief Scientific Officer | Sell | $23.2K |
| Dec 17 | CBIO CRESCENT BIOPHARMA, INC. | Pinkas Jan | Chief Scientific Officer | Grant | $925.0K |
| Jul 16 | CBIO CRESCENT BIOPHARMA, INC. | Pinkas Jan | Chief Scientific Officer | Award | $1.9M |
| Jul 15 | CBIO CRESCENT BIOPHARMA, INC. | Pinkas Jan | Chief Scientific Officer | Other | $0 |
5 filings